Trials / Completed
CompletedNCT02853643
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Asana BioSciences · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and tolerability, and determine the blood levels (pharmacokinetics), in both a fed and fasted condition, of a single dose of ASN002. Healthy volunteers will be participants in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASN002 | Single dose study with food effect |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-11-01
- Completion
- 2016-12-01
- First posted
- 2016-08-03
- Last updated
- 2023-04-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02853643. Inclusion in this directory is not an endorsement.